1. MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma
    Kyosuke Matsuzaki et al, 2017, Oncotarget CrossRef
  2. The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
    M G Davey et al, 2021, BJS Open CrossRef
  3. Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma
    Reem M. Hazem et al, 2021, European Journal of Pharmacology CrossRef
  4. The impact of vascular endothelial growth factor and hypoxia-inducible factor-1α expression on breast cancer: a retrospective analysis
    RashaR Mostafa et al, 2020, Egyptian Journal of Pathology CrossRef
  5. Breast cancer recurrence: factors impacting occurrence and survival
    Donald Courtney et al, 2022, Irish Journal of Medical Science (1971 -) CrossRef
  6. Identification of a Five-MiRNA Expression Assay to Aid Colorectal Cancer Diagnosis
    Matthew G. Davey et al, 2022, Gastrointestinal Disorders CrossRef
  7. Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancer
    M.G. Davey et al, 2021, Surgical Oncology CrossRef
  8. Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population
    Dian Fu et al, 2017, Oncotarget CrossRef
  9. Repression of protocadherin 17 is correlated with elevated angiogenesis and hypoxia markers in female patients with breast cancer
    Sanaa A. El-Benhawy et al, 2021, Cancer Biomarkers CrossRef
  10. Relationship between the cytokine profle of supernatants of invasive breast carcinoma and its molecular and histopathological characteristics
    A. I. Autenshlyus et al, 2024, Siberian journal of oncology CrossRef
  11. Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure
    Fan Dong et al, 2017, Oncotarget CrossRef
  12. Evaluating the Clinical Utility of Routine Sentinel Lymph Node Biopsy and the Value of Adjuvant Chemotherapy in Elderly Patients Diagnosed With Oestrogen Receptor Positive, Clinically Node Negative Breast Cancer
    Matthew G Davey et al, 2021, Breast Cancer: Basic and Clinical Research CrossRef
  13. Maspin expression and subcellular localization in invasive ductal carcinoma of the breast: Prognostic significance and relation to microvessel density
    Duaa S. Helal et al, 2017, Journal of the Egyptian National Cancer Institute CrossRef
  14. Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer
    Sherihan Salaheldin Abdelhamid Ibrahim et al, 2022, Scientific Reports CrossRef
  15. Analyzing the relationship between the cytokine profile of invasive breast carcinoma, its histopathological characteristics and metastasis to regional lymph nodes
    Alexander Autenshlyus et al, 2021, Scientific Reports CrossRef
  16. Defining clinicopathological and radiological features of breast cancer in women under the age of 35: an epidemiological study
    Matthew G. Davey et al, 2020, Irish Journal of Medical Science (1971 -) CrossRef
  17. Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre
    Matthew G. Davey et al, 2021, The Breast Journal CrossRef
  18. Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways
    Xujuan Sun et al, 2018, Cell Death & Disease CrossRef
  19. Saffron anti-metastatic properties, ancient spice novel application
    Laleh Arzi et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  20. MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
    Matthew G. Davey et al, 2022, Cancers CrossRef